Ionis Pharmaceuticals, Inc. (IONS)
60.36
-0.69
(-1.13%)
USD |
NASDAQ |
Aug 31, 16:00
60.35
-0.01
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Long Term Debt (Quarterly) : 2.189B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.189B |
| March 31, 2026 | 2.610B |
| December 31, 2025 | 2.605B |
| September 30, 2025 | 2.049B |
| June 30, 2025 | 1.975B |
| March 31, 2025 | 1.958B |
| December 31, 2024 | 1.950B |
| September 30, 2024 | 1.985B |
| June 30, 2024 | 1.977B |
| March 31, 2024 | 1.969B |
| December 31, 2023 | 1.959B |
| September 30, 2023 | 1.975B |
| June 30, 2023 | 2.009B |
| March 31, 2023 | 1.875B |
| December 31, 2022 | 1.362B |
| September 30, 2022 | 1.254B |
| June 30, 2022 | 1.253B |
| March 31, 2022 | 1.252B |
| December 31, 2021 | 1.248B |
| September 30, 2021 | 1.245B |
| June 30, 2021 | 1.249B |
| March 31, 2021 | 878.60M |
| December 31, 2020 | 630.83M |
| September 30, 2020 | 820.66M |
| June 30, 2020 | 809.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 798.78M |
| December 31, 2019 | 785.53M |
| September 30, 2019 | 674.33M |
| June 30, 2019 | 675.30M |
| March 31, 2019 | 666.08M |
| December 31, 2018 | 646.72M |
| September 30, 2018 | 638.62M |
| June 30, 2018 | 625.84M |
| March 31, 2018 | 614.42M |
| December 31, 2017 | 607.48M |
| September 30, 2017 | 597.65M |
| June 30, 2017 | 604.13M |
| March 31, 2017 | 595.91M |
| December 31, 2016 | 589.10M |
| September 30, 2016 | 495.27M |
| June 30, 2016 | 484.99M |
| March 31, 2016 | 478.90M |
| December 31, 2015 | 481.16M |
| September 30, 2015 | 472.07M |
| June 30, 2015 | 466.90M |
| March 31, 2015 | 462.27M |
| December 31, 2014 | 457.78M |
| September 30, 2014 | 234.76M |
| June 30, 2014 | 233.92M |
| March 31, 2014 | 233.23M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Biogen, Inc. | 8.355B |
| BridgeBio Pharma, Inc. | 3.370B |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |